Jeffrey Scott Sherman Neogenomics Inc (NEO) insider trading activity

Jeffrey Scott Sherman is Chief Financial Officer of NEOGENOMICS INC. Currently has a direct ownership of 168,332 shares of NEO, which is worth approximately $1.21 Million. The most recent transaction as insider was on May 11, 2025, when has been sold 3,167 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K

22.81% 3M change

24.23% 12M change

Total Value Held $1.21 Million

Jeffrey Scott Sherman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2025	SELL Payment of exercise price or tax liability	-	3,167 Reduced 1.85%	168,332 Common Stock
May 11 2025	BUY Exercise of conversion of derivative security	-	13,005 Added 7.05%	171,499 Common Stock
May 02 2025	BUY Open market or private purchase	$150,200 $7.51 p/Share	20,000 Added 11.2%	158,494 Common Stock
Feb 23 2025	SELL Payment of exercise price or tax liability	-	4,207 Reduced 2.98%	137,064 Common Stock
Feb 23 2025	BUY Exercise of conversion of derivative security	-	15,535 Added 9.91%	141,271 Common Stock
Dec 07 2024	SELL Payment of exercise price or tax liability	-	11,746 Reduced 8.67%	123,754 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$47,061 $14.86 p/Share	3,167 Reduced 2.28%	135,500 Common Stock
May 11 2024	BUY Exercise of conversion of derivative security	-	26,010 Added 14.9%	148,505 Common Stock
Dec 07 2023	SELL Payment of exercise price or tax liability	-	8,147 Reduced 6.09%	125,662 Common Stock
Dec 05 2022	BUY Grant, award, or other acquisition	-	133,809 Added 50.0%	133,809 Common Stock

Also insider at

PRVA

Privia Health Group, Inc. Healthcare

EVP, CFO and CAO

JSS